Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News AHA 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Michael O'Riordan

November 10, 2025

News Conference News AHA 2024

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Caitlin E. Cox

November 17, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Daily News

For Predicting CV Risk, Life’s Essential 8 Doesn’t Add Much to Simple 7

Caitlin E. Cox

October 23, 2023

News Daily News

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Yael L. Maxwell

October 12, 2023

News Daily News

Life’s Essential 8 Linked to More Years Free of Chronic Disease

Caitlin E. Cox

February 28, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Daily News

AHA Revamps Life’s Simple 7, Adding Sleep to Create ‘Essential 8’

Todd Neale

June 29, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Caitlin E. Cox

December 16, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

Top Stories in Cardiology: November 2020

Podcast Heart Sounds

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Conference News AHA 2020

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Shelley Wood

November 10, 2020

News Conference News AHA 2019

Early Data Favorable for New RNAi Therapies to Reduce Triglycerides

Caitlin E. Cox

November 19, 2019

News Conference News AHA 2019

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

Shelley Wood

November 18, 2019

Advertisement

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

For Predicting CV Risk, Life’s Essential 8 Doesn’t Add Much to Simple 7

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Life’s Essential 8 Linked to More Years Free of Chronic Disease

Longer-Term ASCVD Risk Assessment Best for Younger Patients

New on the Scene Nonstatin Drugs: Experts Provide Guidance

AHA Revamps Life’s Simple 7, Adding Sleep to Create ‘Essential 8’

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Experts Fear Coronary CT Advice for Patients Misses the Mark

Top Stories in Cardiology: November 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Early Data Favorable for New RNAi Therapies to Reduce Triglycerides

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content